RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:370396

Small cell carcinoma of the ovary

low confidenceDisorder

Also known as: SCCO · Small cell ovarian carcinoma

Publications

915

Trials

2

Interventional, condition-specific

Researchers

1,191

Distinct authors in sample

Gene link

—

Readiness

2/6

Stages with a signal

Clinical definition (Orphanet)

Small cell carcinoma of the ovary is a rare, highly aggressive, poorly differentiated ovarian neoplasm, often associated with paraneoplastic hypercalcemia. It is usually diagnosed in childhood or young adulthood at an advanced stage and presents with abdominal or pelvic mass or, rarely, symptoms related to hypercalcemia. Occasional familial cases have been reported.

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (8)

ovarian small cell NEC · ovarian small cell cancer · ovarian small cell carcinoma · ovarian small cell neuroendocrine carcinoma · ovary small cell carcinoma · small cell carcinoma of ovary · small cell carcinoma of the ovary · small cell ovarian carcinoma

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

2/6 stages with a signal

An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    915 matched papers (652 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialPresent

    2 matched on ClinicalTrials.gov (1 recruiting in sample)

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

915

915 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

915 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

652 in the last 10 years · low confidence

Phrase hits: 915 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

1,191

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.

  1. 01
    Foulkes WD13 papers · 2026

    Department of Human Genetics, McGill University, Montreal, QC, Canada.

    Papers in Europe PMC
  2. 02
    Wang Y8 papers · 2026

    Department of Pathology and Laboratory Medicine, University of British Columbia and Department of Molecular Oncology, British Columbia Cancer Research Institute, Vancouver, Canada.

    Papers in Europe PMC
  3. 03
    Kang Y7 papers · 2026

    Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China.

    Papers in Europe PMC
  4. 04
    McCluggage WG7 papers · 2026

    Department of Pathology, Belfast Health and Social Care Trust, Royal Group of Hospitals Trust, Royal Group of Hospitals, Belfast, UK.

    Papers in Europe PMC
  5. 05
    Zhang Y6 papers · 2026

    Johns Hopkins University School of Medicine, Baltimore, MD.

    Papers in Europe PMC
  6. 06
    Gao Y5 papers · 2025

    Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China.

    Papers in Europe PMC
  7. 07
    Lang JD5 papers · 2025

    Division of Integrated Cancer Genomics, Translational Genomics Research Institute (TGen), Phoenix, United States.

    Papers in Europe PMC
  8. 08
    Witkowski L5 papers · 2026

    Department of Human Genetics, McGill University, Montreal, QC, Canada.

    Papers in Europe PMC
  9. 09
    Zheng K5 papers · 2025

    Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China.

    Papers in Europe PMC
  10. 10
    Chen X4 papers · 2026

    Department of Gynecologic Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of innovative Cancer Diagnosis & Therapeutics, 42# Baiziting street, Nanjing, Jiangsu, 210009, China. cxxxxcyd@gmail.com.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

2

interventional trials for this specific condition

2 interventional trials matched this specific condition name; 1 currently recruiting in our sample. 321 trials are registered for small cell carcinoma, the broader category — shown separately because they may or may not enrol this specific subtype.

Data as of 27 July 2026

2 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 82.4th percentile).

low confidence · 82.4th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

2 interventional trials matched after quoted-phrase search and title/condition post-filter.

Broader category: small cell carcinoma

321

Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.

Worth raising with a clinician. How we count trials.

Recruiting under the broader category

Observational and natural-history studies

1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.

Recruiting or not-yet-recruiting

Open the complete matched search on ClinicalTrials.gov

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Small cell carcinoma of the ovary" OR "Small cell carcinoma of ovary" OR "Small cell ovarian carcinoma" OR "ovarian small cell NEC" OR "ovarian small cell cancer" OR "ovarian small cell carcinoma" OR "ovarian small cell neuroendocrine carcinoma" OR "ovary small cell carcinoma"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Small cell carcinoma of the ovary" OR "Small cell carcinoma of ovary" OR "Small cell ovarian carcinoma" OR "ovarian small cell NEC" OR "ovarian small cell cancer" OR "ovarian small cell carcinoma" OR "ovarian small cell neuroendocrine carcinoma" OR "ovary small cell carcinoma"

Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).

Study-type breakdown: 2 interventional · 1 observational · 1 expanded access. Only interventional studies enter the trial headline.

Parent-category trials query:

"small cell carcinoma"

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Synonyms dropped by stoplist: SCCO

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • 1 synonym(s) dropped by stoplist (may under-count)
  • No label/synonym collisions with other diseases in this corpus
  • Publication count (915) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity

Ingested 2026-07-27T14:57:21.685Z